• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Uncontrolled hypertension: A neglected risk in patients with NAFLD.

作者信息

Kasper Philipp, Martin Anna, Meyer Zu Schwabedissen Albrecht, Scherdel Julia, Lang Sonja, Goeser Tobias, Demir Münevver, Steffen Hans-Michael

机构信息

Clinic for Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Department of Hepatology and Gastroenterology, Campus Virchow Clinic, Charité University Medicine, Berlin, Germany.

出版信息

J Intern Med. 2022 Jul;292(1):162-164. doi: 10.1111/joim.13476. Epub 2022 Mar 6.

DOI:10.1111/joim.13476
PMID:35194872
Abstract
摘要

相似文献

1
Uncontrolled hypertension: A neglected risk in patients with NAFLD.未控制的高血压：非酒精性脂肪性肝病患者中被忽视的风险。
J Intern Med. 2022 Jul;292(1):162-164. doi: 10.1111/joim.13476. Epub 2022 Mar 6.
2
Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?非酒精性脂肪性肝病与高血压：共存还是相关？
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):979-985. doi: 10.1097/MEG.0000000000001191.
3
Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.低剂量（5 毫克）与高剂量（20-40 毫克）瑞舒伐他汀对动脉高血压控制良好的患者 24 小时动脉僵硬度、中心血流动力学和非酒精性脂肪性肝病的影响。
Curr Vasc Pharmacol. 2018;16(4):393-400. doi: 10.2174/1570161115666170630122833.
4
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease.非酒精性脂肪性肝病成人患者的 2 型糖尿病、高血压和血脂异常药物处方趋势。
Ann Hepatol. 2022 Jul-Aug;27(4):100699. doi: 10.1016/j.aohep.2022.100699. Epub 2022 Mar 9.
5
Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.评估非酒精性脂肪性肝病与糖尿病并发症之间的关系。
J Diabetes Investig. 2016 Nov;7(6):889-894. doi: 10.1111/jdi.12518. Epub 2016 Apr 20.
6
Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.接受减肥手术的重度肥胖南印度患者中非酒精性脂肪性肝病的患病率及预测因素
Obes Surg. 2015 Nov;25(11):2078-87. doi: 10.1007/s11695-015-1655-1.
7
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
8
Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.中度至重度而非轻度的非酒精性脂肪性肝病与胆结石病风险增加相关。
Scand J Gastroenterol. 2014 Aug;49(8):1001-6. doi: 10.3109/00365521.2014.920912. Epub 2014 Jul 3.
9
Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan.巴基斯坦开伯尔-普赫图赫瓦省白沙瓦军区非酒精性脂肪肝和非酒精性脂肪性肝炎的患病率
Pak J Pharm Sci. 2018 Jan;31(1):193-198.
10
Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence.澳大利亚墨尔本两家大都市医院的非酒精性脂肪性肝病患者：高风险状态与低患病率
Intern Med J. 2018 Nov;48(11):1369-1376. doi: 10.1111/imj.13973.

引用本文的文献

1
Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model.使用新型临床风险模型检测代谢功能障碍相关脂肪性肝病患者的隐匿性高血压
J Hum Hypertens. 2025 Jul 11. doi: 10.1038/s41371-025-01047-z.
2
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD).纳米技术在非酒精性脂肪性肝病（NAFLD）治疗中的新兴作用。
EXCLI J. 2023 Sep 4;22:946-974. doi: 10.17179/excli2023-6420. eCollection 2023.
3
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study.
脂肪肝的严重程度与高血压和糖尿病风险高度相关：一项横断面和纵向队列研究。
Hepatol Int. 2024 Feb;18(1):138-154. doi: 10.1007/s12072-023-10576-z. Epub 2023 Sep 25.
4
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed.非酒精性脂肪性肝病的筛查策略：需要一种整体方法。
Clin Mol Hepatol. 2023 Apr;29(2):390-393. doi: 10.3350/cmh.2023.0059. Epub 2023 Mar 20.